Corporate Finance

With a new SVP of Global Sales, Slingshot Biosciences is poised to scale its synthetic cell mimic technology, targeting the booming cell therapy market.

With a severe doctor shortage, one company just raised millions to prove nurse practitioners are the future of primary care for America's seniors.

A new multi-year deal gives RNAi leader Alnylam access to Helix's vast genomic and clinical data, aiming to redefine the speed of drug discovery.

With its new FRESHPREY line, premium brand ORIJEN challenges fresh food incumbents, leveraging extreme marketing and a 'WholePrey' philosophy.

Crypto exchange Platov.co adds Turkish, Moldovan, and Kazakh currencies, a strategic move into high-demand markets with complex regulatory landscapes.

Lionsgate and Scentbird's new John Wick perfume is more than a novelty; it's a strategic play in the booming billion-dollar fandom economy.

Raleigh's Levitate lands $16M to expand its AI platform, betting that technology can enhance, not replace, the human element in business relationships.

As AI-generated code introduces new risks, Snyk's partner awards highlight a channel-first strategy to tackle the 'speed paradox' in software security.

FOTRIC's new TK6Kit bundles a true 384x288 thermal camera with a full set of field gear for just $949, making professional-grade inspections accessible.

CIBC's move to pay back $1B in debentures five years ahead of schedule highlights its strong liquidity and proactive capital management strategy.

A new Chinese fantasy drama personifies ancient instruments into living spirits. Here's how 'The Melody of Love' is set to change global entertainment.

A new survey reveals over half of Americans delay healthcare, creating a 'health debt' crisis fueled by cost fears and scheduling conflicts for younger generations.

AI drug discovery firm Proxima appoints three titans of science to its board, signaling a major push in proximity therapeutics to rewrite medicine's rules.

New study shows an AI platform matches expert radiologists in tumor measurement, promising a new era of precision and consistency in breast cancer surgery.

With a total of $160M in Series B funding, Atavistik Bio is advancing its selective allosteric inhibitors for rare diseases HHT and MPNs.

With a new outpatient model, NexCure aims to bring life-saving cancer treatments like CAR-T closer to home, tackling a major healthcare bottleneck.

Investors eye Moody's CEO Rob Fauber's upcoming speech for insights on AI strategy, M&A forecasts, and navigating an increasingly complex global economy.

Top-ranked US advisory firm LSP enters Europe's heated market, tapping veteran Humza Vanderman to lead its new London hub amid a surge in activism.

Syntax Data launches Saidee, an AI that builds custom portfolios using proprietary, traceable data, aiming to solve key compliance fears for financial advisors.

Ad-tech giant Teads reports massive revenue growth post-merger, but a $352M impairment and restructuring signal deep integration challenges.